Global integration has brought sweeping changes in the pharmaceutical industry due to cost constraints that have forced the industry to negotiate for lower “bottom line” costs. The pharmaceutical industry is constantly and rapidly changing because of changes in technology, research and development (R&D), regulations, competition, and demand for pharmaceuticals. Increased competition will drive industry change as the use of less expensive generic and over-the-counter drugs increases because of the rise in managed health care. Companies will focus on streamlining production methods, reducing product development cycles, and reducing costs.
DrewsJRyserS. Innovation deficit in the pharmaceutical industry. Drug Inf J.1996;30(1):97–108.
2.
HallidayRG. Success in pharmaceutical R&D: The different strategies of Western and Japanese companies. Drug Inf J.1996;30(3):821–838.
3.
KeelingP. Research and development demystified in pursuit of innovation. Pharma Bus News.1995;12–16.
4.
Do we pay too much for prescriptions?Consum Rep.1993;668–674.
5.
SchondelmeyerS. Competition and pricing issues in the pharmaceutical market. Minneapolis, MN: PRIME Institute, College of Pharmacy, University of Minnesota; August 1994.
6.
Special Committee on Aging, United States Senate.Earning a Failing Grade: A Report Card on the 1992 Drug Manufacturer Price Inflation. February 1993.
7.
AndersonRJ. Reducing and controlling overhead costs. Drug Inf J.1996;30(1):89–96.
8.
JohnsonGP. A financial coming of age for clinical trial investigators. Drug Inf J.1996;30(1):119–135.
